Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Cerus Corporation - Common Stock (NQ:CERS)

2.080 +0.080 (+4.00%)
Streaming Delayed Price Updated: 4:00 PM EDT, Apr 17, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,411,546
Open 2.070
Bid (Size) 1.970 (200)
Ask (Size) 2.160 (2,800)
Prev. Close 2.000
Today's Range 2.050 - 2.145
52wk Range 1.150 - 2.955
Shares Outstanding 180,552,190
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Cerus Corporation to Release First Quarter 2026 Financial Results on April 30, 2026
From Cerus Corporation
Via Business Wire
News headline image
Cerus Appoints Vivek Jayaraman as President and Chief Executive Officer
From Cerus Corporation
Via Business Wire

Performance

YTD
+5.6%
+5.6%
1 Month
+20.9%
+20.9%
3 Month
-16.1%
-16.1%
6 Month
+27.6%
+27.6%
1 Year
+61.2%
+61.2%

More News

Read More
Cerus Corp (NASDAQ:CERS) Reports Mixed Q4 2025 Results, Stock Falls on Revenue Miss ↗
Via Chartmill
News headline image
Cerus (CERS) Q4 2025 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings World Trade
News headline image
Earnings Scheduled For November 6, 2025 ↗
Via Benzinga
News headline image
Earnings Scheduled For August 5, 2025 ↗
Via Benzinga
News headline image
Cerus Corporation Announces Full-Year and Fourth Quarter 2025 Financial Results
From Cerus Corporation
Via Business Wire
News headline image
Cerus Corporation to Participate in the TD Cowen 46th Annual Health Care Conference
From Cerus Corporation
Via Business Wire
News headline image
Cerus Corporation to Release Fourth Quarter and Full-Year 2025 Financial Results on March 2, 2026
From Cerus Corporation
Via Business Wire
News headline image
DRK Blood Donation Service Baden-Württemberg – Hessen Starts INITIATE Study to Evaluate Pathogen-Inactivated Platelet Concentrates Treated with Cerus’ INTERCEPT™ Blood System in Routine Clinical Practice
From Cerus Corporation
Via Business Wire
News headline image
Cerus Corporation Announces Preliminary Fourth Quarter and Full-Year 2025 Product Revenue and Provides Outlook
From Cerus Corporation
Via Business Wire
News headline image
Cerus Corporation Announces Group Purchasing Agreement with Blood Centers of America
From Cerus Corporation
Via Business Wire
News headline image
12 Health Care Stocks Moving In Thursday's After-Market Session ↗
Via Benzinga
News headline image
Cerus Corporation Announces Record Results for Third Quarter 2025 and Raises Full Year 2025 Product Revenue Guidance
From Cerus Corporation
Via Business Wire
News headline image
Cerus Corporation Announces Abstracts and Industry Workshop on IFC at the 2025 AABB Annual Meeting
From Cerus Corporation
Via Business Wire
News headline image
Cerus Corporation to Release Third Quarter 2025 Financial Results on November 6, 2025
From Cerus Corporation
Via Business Wire
News headline image
The German National Blood Advisory Committee Issues Formal Recommendation for Improving the Safety of Platelet Transfusions
From Cerus Corporation
Via Business Wire
News headline image
Cerus Corporation to Participate in the Cantor Global Healthcare Conference 2025
From Cerus Corporation
Via Business Wire
News headline image
Cerus Corporation Announces Second Quarter 2025 Financial Results
From Cerus Corporation
Via Business Wire
News headline image
Cerus Corporation to Release Second Quarter 2025 Financial Results on August 5, 2025
From Cerus Corporation
Via Business Wire
News headline image
Cerus Corporation Announces Additional Department of Defense Award to Advance Care for Major Hemorrhage in Traumatic Injury
From Cerus Corporation
Via Business Wire
News headline image
12 Health Care Stocks Moving In Wednesday's After-Market Session ↗
Via Benzinga
News headline image
Get insights into the top gainers and losers of Wednesday's after-hours session. ↗
Via Chartmill
News headline image
Cerus Corporation Provides INTERCEPT Red Blood Cell CE Mark Application Update
From Cerus Corporation
Via Business Wire
News headline image
Cerus Corporation Celebrates World Blood Donor Day 2025
From Cerus Corporation
Via Business Wire

Frequently Asked Questions

Is Cerus Corporation - Common Stock publicly traded?
Yes, Cerus Corporation - Common Stock is publicly traded.
What exchange does Cerus Corporation - Common Stock trade on?
Cerus Corporation - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Cerus Corporation - Common Stock?
The ticker symbol for Cerus Corporation - Common Stock is CERS on the Nasdaq Stock Market
What is the current price of Cerus Corporation - Common Stock?
The current price of Cerus Corporation - Common Stock is 2.080
When was Cerus Corporation - Common Stock last traded?
The last trade of Cerus Corporation - Common Stock was at 04/17/26 04:00 PM ET
What is the market capitalization of Cerus Corporation - Common Stock?
The market capitalization of Cerus Corporation - Common Stock is 375.55M
How many shares of Cerus Corporation - Common Stock are outstanding?
Cerus Corporation - Common Stock has 376M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.